Autoimmune News: Breaking Autoimmune News, Comments and Articles. - Page: 5

Metagenics Announces Lifestyle Medicine Summit on Women’s Health: “What Women Really Want”

Seventeen Renowned Experts to Present at Second Annual Event Metagenics, Inc., a nutrigenomics and lifestyle medicine company focused on improving health, will host its second annual Lifestyle Medicine Summit in Chicago on October 4-6, 2013. The Summit will feature 17 distinguished experts who will discuss “What Women Really Want” related to their...

Molecular Diagnostics Being Developed for Underserved Diagnostic Markets

Two companies are collaborating to develop novel molecular diagnostics for autoimmune, cancer, and infectious diseases, among others.

Mystery Behind Sex Disparities In Drug-Induced Hepatitis Unravelled In Mouse Model

A life-threatening condition that often requires transplantation and accounts for half of all acute liver failures, autoimmune hepatitis is often precipitated by certain anesthetics and antibiotics. Researchers say these drugs contain tiny molecules...

Lupus Research Institute Tops $170 Million for Novel Research in Lupus

NEW YORK, May 1, 2013 /PRNewswire/ -- The Lupus Research Institute (LRI) announces a new $170 million milestone -- delivering unprecedented novel research funding and unprecedented research results -- changing the lives of lupus patients.  A new analysis of completed LRI Novel Research grants demonstrates an 84 percent success rate as scientists prove cutting-edge hypotheses, publish res...

Boost Your Immune System With Boogers For Lunch?

Michael Harper for redOrbit.com – Your Universe Online Scott Napper certainly has a way of making a first impression. In his biochemistry classes at the University of Saskatchewan in Saskatoon, Canada, Napper poses the following question to his first year students: “Does eating your boogers boost your immune system?” This, says Napper, gets the students instantly engaged in the class, ex...

Lupus Foundation of America Calls on the Public to Take Action to Expand Medical Research on Lupus

WASHINGTON, May 1, 2013 /PRNewswire-USNewswire/ -- The Lupus Foundation of America is calling on all Americans to join the fight against lupus this May during Lupus Awareness Month and take action to help expand lupus research efforts.  Lupus is a mysterious and devastating disease that ravages different parts of the body and has no known cause and no known cure.  (Logo: http://ph...

Resverlogix's Board Approves Arrangement to Spin-Out RVX Therapeutics Inc. and Confirms Special Meeting of Shareholders

TSX Exchange Symbol: RVX CALGARY, May 1, 2013 /PRNewswire/ - Resverlogix Corp. (TSX:RVX) ("Resverlogix") today announced that its Board of Directors has unanimously approved the previously announced Plan of Arrangement ("the Arrangement") to spin-out its subsidiary RVX Therapeutics Inc. ("RVX Therapeutics"). Resverlogix has entered into an Arrangement Agreement with RVX Therapeutics and 17...

Celsus Therapeutics Strengthens Board of Directors With Addition of Dermatology Industry Veteran Robert F. Doman

NEW YORK, NY and LONDON -- (Marketwired) -- 05/01/13 -- Celsus Therapeutics (OTCQB: MRRBY), an emerging growth, development-stage biotech company, announced the addition of industry veteran Robert F. Doman to the Company's Board of Directors. "We are pleased that Bob has joined our board of directors," said Gur Roshwalb, Chief Executive Officer of Celsus Therapeutics. "He brings more than 30 yea...

Study finds key protein for firing up central nervous system inflammation

(University of Texas M. D. Anderson Cancer Center) Scientists have identified an influential link in a chain of events that leads to autoimmune inflammation of the central nervous system in a mouse model of multiple sclerosis.

JIA Susceptibility: 14 New Genes Found

New data may have opened the way to individualized treatment of juvenile arthritis, including with drugs already used in other autoimmune disorders. Medscape Medical News

Estrogen fuels autoimmune liver damage

A life-threatening condition that often requires transplantation and accounts for half of all acute liver failures, autoimmune hepatitis is often precipitated by certain anesthetics and antibiotics. Researchers say these drugs contain tiny molecules...

Frost & Sullivan Acknowledges Euro Diagnostica AB's Excellence in Product Differentiation

LONDON , April 30, 2013 /- Based on its recent analysis of the autoimmune disease diagnostics market, Frost & Sullivan recognises Euro Diagnostica AB with the 2013 Europe Product Differentiation Excellence Award. "Euro Diagnostica offers a ra...

BioLineRx to Report First Quarter 2013 Results on May 7, 2013

BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a biopharmaceutical development company, announced today that it will release its unaudited financial results for the quarter ended March 31, 2013 on Tuesday, May 7, 2013, before the U.S. markets open. The Company will host a conference call on Tuesday, May 7 at 10:00 a.m. EDT, featuring remarks by Kinne...

Ligand Acquires Financial Rights to More Than 15 Fully-Funded Development Programs from Selexis SA

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) has acquired a portfolio of potential future milestone and royalty payments for more than 15 biologic development programs from Selexis SA. Each acquired program is fully funded by a development partner. Geneva, Switzerland-based Selexis is a privately held global life science company focused on drug disco...

Prometheus Launches New Adalimumab Drug And Antibody Levels Monitoring Test

SAN DIEGO, April 30, 2013 /PRNewswire/ -- Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, announced today the US market launch of its proprietary new test, PROMETHEUS® Anser™ ADA.  This novel test measures drug (adalimumab) and drug antibody levels in one serum sample in inflammatory bowel disease (IBD) patients using adalimumab (ADA) – helpin...

TNI BioTech, Inc. Appoints Industry Veteran, Dr. Joseph Fortunak, as a Strategic Consultant

BETHESDA, Md., April 30, 2013 /PRNewswire/ -- TNI BioTech, Inc. (OTC PINK: TNIB) announced today the appointment of industry veteran, Dr. Joseph M. Fortunak, as a strategic consultant to the company. Dr. Fortunak is the former director and head of Global Chemical Development at Abbott Laboratories Corporation, where he managed more than 350 scientists and technical experts. Dr. Fortunak spen...

Frost & Sullivan Acknowledges Euro Diagnostica AB's Excellence in Product Differentiation

LONDON, April 30, 2013 /PRNewswire/ -- Based on its recent analysis of the autoimmune disease diagnostics market, Frost & Sullivan recognises Euro Diagnostica AB with the 2013 Europe Product Differentiation Excellence Award. "Euro Diagnostica offers a range of high-quality enzyme linked immunosorbent assay (ELISA) kits for autoimmune diagnostics," noted Frost & Sullivan Senior R...

Celsus Therapeutics Strengthens Board of Directors With Addition of Pharma/Biotech Industry Veteran Fredric Price

NEW YORK, NY and LONDON -- (Marketwired) -- 04/30/13 -- Celsus Therapeutics (OTCQB: MRRBY), an emerging growth, development-stage biotech company, announced the addition of Pharma/Biotech industry veteran Fredric Price to the Company's Board of Directors. "We are pleased to have Fred join our board of directors," said Gur Roshwalb, Chief Executive Officer of Celsus Therapeutics. "He brings many...

Stellar Biotechnologies Announces Publication of "Expert Review" Article on Clostridium Difficile Vaccines

PORT HUENEME, CA -- (Marketwired) -- 04/30/13 -- Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (OTCQB: SBOTF) (TSX VENTURE: KLH), the world leader in sustainable manufacture of Keyhole Limpet Hemocyanin (KLH), today announced publication of a peer-review article on Clostridium difficile ("C. difficile") in the current issue of Expert Review of Vaccines (April 2013, Vol. 12, No.4.)....

Ligand Acquires Bio-Portfolio from Selexis

Expands presence in oncology, inflammation and autoimmune diseases

Islet Sciences Receives Japanese Patent Covering New Medications for Diabetes

Islet Sciences, Inc., (OTC.BB: ISLT) a biotechnology company engaged in the research, development and commercialization of patented technologies for people with diabetes, announced today the receipt of a Japanese Patent for allowed claims, Patent Application No. 2008-529208. “This patent is another aspect to the value of our therapies which repr...

Lycera Appoints Bruce Goldsmith, Ph.D., as Chief Business Officer

Lycera Corp., a biopharmaceutical company pioneering the development of breakthrough oral medicines to treat autoimmune diseases, today announced the appointment of Bruce A. Goldsmith, Ph.D., as chief business officer. In this new position, Dr. Goldsmith will work as part of the executive team to implement the company’s corporate strategy and will...

Teva Expands Management Team with Appointment of Paul J. Sekhri as Group Executive Vice President, Global Business Development and Chief Strategy Officer

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) today announced that Paul J. Sekhri has been appointed Group Executive Vice President, Global Business Development and Chief Strategy Officer. Mr. Sekhri has over 25 years of operational experience in the life sciences industry, including business development, business strategy, general management, drug deve...

MS sufferers 'facing care lottery'

Multiple sclerosis (MS) sufferers are facing a care “lottery”, a charity has warned, after a damning report found that as many as 60% of patients are not receiving life-improving drugs for the incurable autoimmune disease.

Thymus-derived regulatory T cells contribute to tolerance to commensal microbiota

Peripheral mechanisms preventing autoimmunity and maintaining tolerance to commensal microbiota involve CD4+ Foxp3+ regulatory T (Treg) cells generated in the thymus or extrathymically by induction of naive CD4+ Foxp3− T cells. Previous studies sug...